Related Experiment Videos
Bridging to cardiac transplantation.
1Department of Cardiovascular Surgery, Pacific Presbyterian Medical Center, San Francisco, California 94115.
The Annals of Thoracic Surgery
|January 1, 1989
Summary
Prosthetic ventricles and artificial hearts offer a 4-year bridge to cardiac transplantation for patients with rapidly deteriorating conditions. Device selection is crucial for successful outcomes in these critical heart failure patients.
Area of Science:
- Cardiovascular Surgery
- Biomedical Engineering
- Transplantation Medicine
Background:
- Prosthetic ventricles and artificial hearts have been utilized for bridging to transplantation for four years.
- Patients requiring a bridge to transplantation often face rapid deterioration or sudden cardiac decompensation, such as massive myocardial infarction with cardiogenic shock.
- Careful patient selection is paramount to ensure suitability for heart transplantation despite their critical condition.
Purpose of the Study:
- To compare the outcomes of various artificial heart devices used for bridging to cardiac transplantation.
- To evaluate the efficacy of different prosthetic ventricles in managing patients with end-stage heart failure awaiting transplantation.
Main Methods:
- Review and comparison of clinical results from available bridging devices.
- Analysis of patient selection criteria for cardiac transplantation in deteriorating candidates.
- Inclusion of devices such as the centrifugal pump, Jarvik-7 orthotopic prosthetic ventricle, and heterotopic prosthetic ventricles (Thoratec, Novacor, Thermedics).
Main Results:
- The study compares the performance of different artificial heart technologies.
- Outcomes are assessed for patients bridging to transplantation using various prosthetic ventricular devices.
- The selection of appropriate candidates who are good transplant recipients despite rapid decline is highlighted.
Conclusions:
- The use of prosthetic ventricles and artificial hearts provides a vital option for bridging to transplantation.
- Effective patient selection is critical for optimizing outcomes in this high-risk population.
- Comparative data on available devices aids in clinical decision-making for artificial heart support.